METOO FILL+ DEEP with Lidocaine

METOO FILL+ DEEP with Lidocaine

METOO FILL+ DEEP is a cross-linked hyaluronic acid dermal filler from Maypharm, South Korea. It is the medium-firmness gel in the METOO FILL+ range and is designed for injection into the mid-to-deep dermis for moderate to deep wrinkles and folds and lip contour. It contains 0.3% lidocaine to improve comfort during injection. Each box contains one 1.1 ml pre-filled syringe with two 27G needles. For use by licensed physicians only.

Key Features

• Designed for Wrinkles, Folds and Lips: A medium-firmness gel injected into the mid-to-deep dermis.
• Cross-Linked Hyaluronic Acid: 24 mg/ml. According to the manufacturer, the gel is produced with a multi-stage cross-linking process followed by multi-step purification.
• With 0.3% Lidocaine: Helps reduce discomfort during injection.
• Reversible: Hyaluronic acid can be dissolved with hyaluronidase by a qualified practitioner.

The METOO FILL+ Range

The METOO FILL+ range includes fillers with different gel firmness. The physician selects the product according to the treatment area and tissue depth.

• METOO FILL+ LIGHT: The softest gel, for fine lines.
• METOO FILL+ DEEP: Medium firmness, for moderate to deep wrinkles, folds and lips, injected into the mid-to-deep dermis.
• METOO FILL+ VOLUME: The firmest gel, for volume and contour.

Intended Use

• Nasolabial folds
• Marionette lines
• Perioral lines
• Lip contour and lip volume

Treatment area, injection depth, technique and volume must follow the official Instructions for Use and the treating physician’s assessment. Results and duration vary between individuals.

Product Specifications

• Brand: METOO
• Product: METOO FILL+ DEEP (with lidocaine)
• Company: Maypharm Co., Ltd.
• Origin: South Korea
• Composition: Cross-linked hyaluronic acid 24 mg/ml, lidocaine hydrochloride 0.3%
• Injection Depth: Mid-to-deep dermis
• Contents: 1 × 1.1 ml pre-filled syringe, 2 × 27G needles
• Shelf Life: Refer to the carton for the expiry date.
• Product Type: Hyaluronic acid dermal filler (medical device)

Administration

• For use only by licensed physicians trained in facial anatomy, filler injection techniques and the management of filler complications.
• Check that the packaging is intact and the product is within its expiry date before use.
• Inject under aseptic conditions at the depth specified in the IFU. Inject slowly in small amounts with low pressure.
• Not intended for very superficial fine lines or deep volume restoration. Other products in the range are designed for these indications.
• Confirm the patient has no allergy to lidocaine or other amide-type local anaesthetics before use.
• Each syringe is for a single patient. Injection technique, volume and treatment interval must follow the IFU and the treating physician’s judgment.
• Do not self-administer.

Contraindications

General contraindications for hyaluronic acid fillers containing lidocaine are listed below. Refer to the official Instructions for Use for the complete list.

• Known hypersensitivity to hyaluronic acid, lidocaine or other amide-type local anaesthetics
• History of severe allergies or anaphylaxis
• Active infection, inflammation, wounds or skin disease at or near the injection site
• Pregnancy or breastfeeding
• Persons under 18 years of age

Who Should Consult a Physician First

• People with autoimmune disease, diabetes or epilepsy
• People with bleeding disorders or taking anticoagulant or antiplatelet medication
• People with a history of cold sores (herpes labialis), especially before lip or perioral treatment
• People with a tendency to hypertrophic scars or keloids
• People with heart rhythm disorders, severe liver disease or porphyria
• People with permanent fillers or implants in the treatment area

Precautions

• Common reactions include redness, swelling, pain, tenderness, itching and bruising at the injection site. Swelling of the lips can be pronounced in the first days.
• Lumps, nodules, asymmetry, product migration, infection and delayed inflammatory reactions may occur.
• Accidental injection into a blood vessel can cause vascular occlusion, skin necrosis and, rarely, visual impairment or blindness. The nasolabial fold (near the angular artery), the lips (labial arteries) and the area below the corners of the mouth require particular care.
• Hyaluronic acid can be dissolved with hyaluronidase. Practitioners should keep hyaluronidase and an emergency protocol available.
• Seek medical attention immediately for severe or increasing pain, skin blanching or colour change, or any change in vision after treatment.
• Do not use if the packaging is open or damaged, the syringe is cracked or the product is past its expiry date.
• Single use only. One syringe, one patient. Do not re-sterilise. Keep out of reach of children.

After Treatment

Follow the aftercare instructions given by the treating physician. Strenuous exercise, heat exposure and pressure or massage on the treated area are generally avoided for the first 24 hours, unless the physician advises otherwise. Report any adverse reaction to the treating physician.

Storage

Store as indicated on the carton. Protect from direct sunlight and freezing. Refer to the carton for the expiry date.

Package Contents

• 1 × 1.1 ml pre-filled syringe of METOO FILL+ DEEP
• 2 × 27G needles
• Instructions for Use

Important Notice

For professional healthcare use only. This information is for general product reference. It does not replace medical advice, the official Instructions for Use or local regulations. This product is not intended to diagnose, treat, cure or prevent any disease. Results vary between individuals.